Why the study?
Does HDL or apoA-I reduce CD11b activation and inflammatory responses in human monocytes?
Population
Human monocytes isolated from whole blood, including monocytes derived from a Tangier disease patient.
Design
Preclinical
Authors
Loading...
May attenuate monocyte inflammation via ABCA1; hypothesis-generating for atheroprotection, requiring human trials.
Does HDL or apoA-I reduce CD11b activation and inflammatory responses in human monocytes?
This study provides mechanistic evidence that HDL and apoA-I reduce monocyte inflammation via ABCA1-mediated cholesterol efflux, highlighting a potential atheroprotective pathway.
Murphy et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: